Articles by F Fang (4)

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies

S Goel, A. C Mita, M Mita, E. K Rowinsky, Q. S Chu, N Wong, C Desjardins, F Fang, M Jansen, D. E Shuster, S Mani and C. H. Takimoto

Clinical Cancer Research 15 ( 12 ): 4207 - 4212 , 2009

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

A. R Tan, E. H Rubin, D. C Walton, D. E Shuster, Y. N Wong, F Fang, S Ashworth and L. S. Rosen

Clinical Cancer Research 15 ( 12 ): 4213 - 4219 , 2009

Immediate Risk of Suicide and Cardiovascular Death After a Prostate Cancer Diagnosis: Cohort Study in the United States

F Fang, N. L Keating, L. A Mucci, H. O Adami, M. J Stampfer, U Valdimarsdottir and K. Fall

JNCI J Natl Cancer Inst 102 ( 5 ): 307 - 314 , 2010

Regulation of NAB2 mRNA 3'-end formation requires the core exosome and the Trf4p component of the TRAMP complex

K. M Roth, J Byam, F Fang and J. S. Butler

RNA 15 ( 6 ): 1045 - 1058 , 2009

Do you have a suggestion for journals

Suggest Journal